市場調查報告書
商品編碼
1422077
全球膝關節置換市場評估:依手術類型、植入物類型、最終用戶、地區、機會和預測(2017-2031)Knee Replacement Market Assessment, By Procedure Type, By Implant Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球膝關節置換市場總規模預計將從 2023 年的 101 億美元增至 2031 年的 153.6 億美元,在 2024-2031 年預測期內複合年增長率為 5.38%。 全膝關節置換術(也稱為膝關節置換術)是一種使用金屬、塑膠或陶瓷植入物來糾正膝關節損傷的外科手術。 這些手術旨在減輕膝蓋受傷引起的疼痛和痛苦。 由於關節炎等與年齡相關的膝蓋疾病,老年人經常接受此類手術。
由於膝骨關節炎的盛行率不斷增加,全膝關節置換市場正在呈現成長。 最容易受到膝關節損傷的老年人口不斷增長,推動了全膝關節置換手術的需求。 此外,微創手術和全膝關節置換術中使用的植入物的技術進步保持了市場持續擴張的趨勢。 世界各地膝骨關節炎和膝關節相關損傷的流行增加了全膝關節置換手術的需求。 全膝關節置換手術在 55 歲及以上的人群中很常見,世界各地老年人口的不斷增長,特別是在日本和美國等國家,進一步推動了市場的成長。
根據 OECD 數據,平均每 10 萬人中有 174 例髖關節置換術和 137 例膝關節置換術。 瑞士和芬蘭等歐洲國家在經合組織國家中進行的全膝關節置換手術數量最多。
膝骨關節炎的高盛行率對於全膝關節置換市場的擴大至關重要。 骨關節炎影響骨關節,大多數病例涉及膝關節。 55歲以上的女性更容易罹患骨關節炎。 老年人因骨骼退化和滑液流失而患有骨關節炎,而女性則患有缺鈣症。 根據最近的估計和預測,預計骨關節炎病例在預測年內將會增加。
例如,根據世界衛生組織2023年7月發布的情況說明書,全球有超過5.28億人患有骨關節炎,其中約3.65億人的膝蓋患有骨關節炎。相關病例需要全膝關節置換等解決方案。 這5.28億人中大約73%是55歲以上的人,其中60%是女性。
植入物、微創手術和全膝關節置換手術領域的技術進步對全膝關節置換市場的成長做出了重大貢獻。 精確的肢體對齊、改進的植入物定位精確度和植入物尺寸的進步使患者能夠順從。 手術機器人、人工智慧、3D 列印和電腦導航等工具可以幫助提供更好的膝關節置換術。 對準確性和精密度的需求正在推動製造商設計創新的解決方案,進一步促進市場成長。
例如,2023 年 10 月,Medacta Group S.A. 宣布推出 GMK SpheriKA,這是世界上第一個用於全膝關節置換術的運動學對準優化股骨組件。 Medacta Group S.A. 是一家總部位於瑞士的公司,為運動醫學、關節置換和脊椎手術提供個人化、創新和永續的解決方案。
政府對研發的投資顯著增強了全膝關節置換市場。 政府旨在透過改革醫療器材法規和為關節置換提供補貼來降低關節置換成本的措施正在顯著推動市場成長。 此外,免稅和與知名製造商的合作增加了國內產量並減少了對進口的依賴。 這些措施將提高全膝關節置換手術的可近性和可負擔性,將某些國家確立為全膝關節置換市場的關鍵國家,並促進醫療保健領域的經濟成長和創新。
例如,美國政府的關節置換綜合護理 (CJR) 模式計劃於 2024 年 12 月完成八個實施年 (PY)。 該計劃是 Medicare A 部分和 B 部分支付模式,旨在為接受髖關節、膝關節和踝關節置換術(也稱為下肢關節置換術)的患者提供融資。 該計劃八年來取得了巨大成功,是政府努力支持全膝關節置換市場的一個很好的例子。
本報告研究和分析了全球全膝關節置換市場,提供市場規模和預測、市場動態、主要參與者趨勢和前景等。
Global knee replacement market is projected to witness a CAGR of 5.38% during the forecast period 2024-2031, growing from USD 10.1 billion in 2023 to USD 15.36 billion in 2031. Knee replacement (also known as knee arthroplasty) is a surgical procedure to rectify knee damage using implants made of metal, plastic, or ceramics. These surgeries aim to relieve the pain and suffering caused by knee damage. The elderly population is the major recipient of such surgeries due to age-associated knee problems like arthritis.
The knee replacement market is experiencing growth due to the growing prevalence of osteoarthritis. The rising geriatric population, which is most prone to knee damage, is fueling the demand for knee replacements. Furthermore, technological advances in minimally invasive surgeries and implants used for knee replacements sustain a tendency for continual market expansion. The rising prevalence of osteoarthritis and knee-associated damage across the globe is increasing the demand for more knee replacement surgeries. Knee replacement surgeries are more common in old-age people above the age of 55 years, thus, the growing geriatric population globally and especially in countries like Japan and United States, further propelling the market growth.
As per OECD data, on average 174 hip replacements per 100,000 people, and 137 knee replacements per 100,000 people are being performed. European countries like Switzerland, Finland, and others are leading the number of knee replacements among OECD countries.
The high prevalence of knee-associated osteoarthritis is critical for the expansion of the knee replacement market. Osteoarthritis affects bone joints, and most of the cases are related to knee joints. People over the age of 55 years and female population are highly susceptible to osteoarthritis. The old age population is affected by osteoarthritis due to degenerative bones and reduced synovial fluid while females are affected because of calcium deficiency. As per recent estimates, osteoarthritis cases are expected to grow during the forecasted years.
For instance, according to the WHO factsheet published in July 2023, more than 528 million people are affected by osteoarthritis across the world, out of which around 365 million cases are knee-associated, which requires solutions like knee replacements. Around 73% of these 528 million cases are contributed by the population above the age of 55 years and 60% of these cases belong to female population.
Technological advancements in the field of implants, minimally invasive surgeries, and knee replacement solutions are major contributors to the growth of the knee replacement market. Advancements such as precise limb alignment, improved accuracy in implant positioning, and implant sizing are enabling patient compliance. Surgical robotics, artificial intelligence, 3D printing, and computer navigation are some of the tools that help in achieving better quality knee replacement solutions. The need for accuracy and precision is driving manufacturers to design innovative solutions, further enhancing market growth.
For example, in October 2023, Medacta Group S.A. announced the launch of GMK SpheriKA, which is the world's first kinematic alignment-optimized femoral component indicated for total knee replacement. Medacta Group S.A. is a Switzerland-based company offering personalized, innovative, and sustainable solutions for sports medicine, joint replacement, and spine surgeries.
The government's investment in research and development has considerably enhanced the knee replacement market. Government initiatives aim to reduce the cost of joint replacement surgeries by reforming the medical device regulations and providing subsidies for such surgeries have significantly boosted the market growth. Furthermore, tax exemptions and collaborations with prominent manufacturers have increased domestic output, lowering reliance on imports. These actions have increased the availability and affordability of knee replacement surgeries establishing specific countries as vital players in the knee replacement market, promoting economic growth and technical innovation in the health care sector.
For example, the Comprehensive Care for Joint Replacement (CJR) Model of the United States government is going to complete eight performance years (PYs) in December 2024. The program is a Medicare Part A and B payment model that aims to facilitate finances for patients with hip, knee, and ankle replacements, also called lower extremity joint replacements. The program has been a major success over the course of 8 years and is a good example of government initiatives to support the knee replacement market.
Total knee replacements have established their dominance with strong statistics in the market. Total knee replacement is one of the most effective and cost-efficient procedures for knee surgeries. It is most commonly done for patients suffering from highly painful, end-stage knee arthritis. Market data shows that there is a growing need for total knee replacement procedures owing to the growing geriatric population and decline in nutritional intake. Advancements in robotic-assisted surgeries and implant designing are anticipated to sustain the dominance of the total knee replacement segment within the knee replacement market.
For instance, in February 2023, as per the press release by CK Birla Hospital, Delhi, more than 2.5 lakh total knee replacement surgeries are performed in India every year, and the number has increased almost three times during the last five years.
The knee replacement market is becoming dominant in the North American region. The region is anticipated to dominate the market with the highest value share due to its significant investment in research and development, technical breakthroughs made by major market players, and highly developed healthcare infrastructure in North American countries like the United States and Canada. The market is expanding in the region because of encouraging government initiatives and a favorable reimbursement environment for handling the rising number of surgical procedures. Regulatory approvals and further market expansion are also beneficial to manufacturers. A growing number of knee surgeries is also contributing to the market growth. For instance, the American College of Rheumatology estimates that 790,000 knee operations are performed in the United States each year.
For instance, in April 2023, the USFDA approved the MISHA Knee System, manufactured by Moximed, Inc. for marketing in the United States. MISHA Knee System is an implant placed alongside the knee joint which helps in reducing the weight load and saving knee damage without removing the knee joint.
Growing prevalence of osteoporosis among the geriatric population and females is majorly driving the demand in the knee replacement market.
Rising geriatric population which is more prone to knee damage across the globe is drastically contributing to the knee replacement market.
Total knee replacement is the leading segment in the knee replacement market due to the high demand and volume of surgeries being performed.
Increasing adoption of surgical robotics for knee replacement surgeries as it offers reduced pain, fewer complications, and increased accuracy.
Key participants in the knee replacement market include: Zimmer Biomet Holdings Inc, B. Braun Melsungen AG, Smith & Nephew plc, Stryker Corporation, and Johnson & Johnson Services, Inc. characterizes this landscape, as these companies compete to outperform one another in terms of patient compliance, safety, accuracy, and unique features. The market prognosis remains positive, owing to increased demand for knee replacement surgeries. Knee replacement solution manufacturers are actively involved in designing innovative solutions. Collaborations and modern technologies are projected to increase competition in the market.
In March 2023, Stryker announced the launch of Mako Total Knee 2.0, at the AAOS 2023 annual meeting in Las Vegas. Mako Total Knee 2.0 is unveiled with new features like customizable workflow, intuitive design, innovative digital tensioner that allows surgeons to analyze the knee's stability during total knee arthroplasty without the need for further instrumentation. Mako Total Knee 2.0 has three key components, AccuStop haptic technology, 3D CT-based planning, and insightful data analytics.
In November 2023, Salona Global announced the launch of the Biodex SpaceTek Knee device, which is developed in collaboration with NASA to be used in space as well. Biodex SpaceTek Knee device is a revolutionary portable isokinetic knee dynamometer medical device for treating patients with knee replacements and knee injuries. The FDA approval for the product is still in progress.
All segments will be provided for all regions and countries covered:
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.